Recruiting

Trifocal IOL

Sponsor:

Vance Thompson Vision ND

Code:

NCT04545073

Conditions

Refractive Errors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

PanOptix

Study Details

Brief summary:

To compare the prediction error of ORA vs formula for post-LASIK cataract patients when PanOptix IOL was implanted. Using post-operative outcomes to determine if preoperative IOL calculations, including Barrett TK, Barrett Universal II, Hill RBF, ASCRS post-refractive calculator, or intraoperative aberrometry is more accurate when the two methods disagree in patients who have had previous refractive surgery undergo cataract surgery.

Conditions

Refractive Errors

Study ID

NCT04545073

Start date

Oct 9, 2020

Status verified date

Oct, 2020

Completion date

May, 2021

Anticipated

Primary completion date

Mar, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Previous myopic refractive surgery
  • At least 3 months post op cataract surgery with a trifocal IOL

Exclusion Criteria:

  • Pre-existing or subsequent eye condition that interferes with accurate data collection (retinal detachment, etc.)

Study Design

Enrollment

200 participants

Anticipated

Interventions and Outcome Measures

Arms

Post-refractive trifocal IOL

Interventions

PanOptix

Trifocal IOL with ORA in post refractive patients

Primary outcome measure

  • To determine if preoperative IOL calculations or intraoperative aberrometry is more accurate when the two methods disagree in patients who have had previous refractive surgery undergo cataract surgery. [ Time Frame: Pre-op to 9 month visit ]

Central Contacts and Locations

Central contacts

Sarah Thiede

7015665390sarah.thiede@vancethompsonvision.com

Locations

Vance Thompson Vision ND

Recruiting

W. Fargo, North Dakota, United States, 58078

Contacts

Sarah Thiede

701-566-5390sarah.thiede@vancethompsonvision.com

Jake Hutchison

701-566-5390jake.hutchison@vancethompsonvision.com

Principal Investigator:

Michael Greenwod, MD

More Information

Sponsor

Vance Thompson Vision ND

Last update posted

Oct 19, 2020

Last verified

Oct, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vance Thompson Vision ND on 2020-10-19.